Trial
NCT05011396
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VistaGen Therapeutics, Inc.
Collaborators
—
Condition
Social Anxiety Disorder
Intervention
PH94B Nasal Spray
Why stopped
Study stopped by the sponsor for business reasons and not due to any safety concerns with PH94B
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-24